Skip to main content

CORRECTION article

Front. Immunol., 10 November 2022
Sec. Multiple Sclerosis and Neuroimmunology
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1052766

Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis

This article is a correction to:

  1. Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

    1. Read original article
Hui Xia,&#x;Hui Xia1,2†Ziyao Wang,&#x;Ziyao Wang1,2†Min TianMin Tian2Zunjing Liu*Zunjing Liu2*Zhenhua Zhou*Zhenhua Zhou3*
  • 1Graduate School of Beijing University of Chinese Medicine, Beijing, China
  • 2Department of Neurology, China-Japan Friendship Hospital, Beijing, China
  • 3Department of Neurology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China

A corrigendum on:
Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis.

by Xia H, Wang Z, Tian M, Liu Z and Zhou Z (2022) 13:823391. doi: 10.3389/fimmu.2022.823391

In the published article, there was an error regarding the affiliations for Hui Xia and Ziyao Wang. As well as having the affiliation “Department of Neurology, China-Japan Friendship Hospital, Beijing, China”, they should also have “Graduate School of Beijing University of Chinese Medicine, Beijing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: ischemic stroke, stroke subtype, large-artery stenosis, low-molecular-weight heparin, aspirin

Citation: Xia H, Wang Z, Tian M, Liu Z and Zhou Z (2022) Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis. Front. Immunol. 13:1052766. doi: 10.3389/fimmu.2022.1052766

Received: 24 September 2022; Accepted: 20 October 2022;
Published: 10 November 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Xia, Wang, Tian, Liu and Zhou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zunjing Liu, bGl1enVuamluZ0AxNjMuY29t; Zhenhua Zhou, ZXhwbG9pdGVyMDAxQDEyNi5jb20=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.